Imitrex: Targeted Relief for Acute Migraine Attacks
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $5.59 | $167.56 (0%) | 🛒 Add to cart |
| 60 | $5.17 | $335.11 $310.03 (7%) | 🛒 Add to cart |
| 90 | $5.03 | $502.67 $452.50 (10%) | 🛒 Add to cart |
| 120 | $4.95
Best per pill | $670.22 $593.97 (11%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $4.92 | $147.49 (0%) | 🛒 Add to cart |
| 60 | $4.41 | $294.98 $264.88 (10%) | 🛒 Add to cart |
| 90 | $4.25 | $442.47 $382.27 (14%) | 🛒 Add to cart |
| 120 | $4.16
Best per pill | $589.96 $498.66 (15%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $6.12 | $183.61 (0%) | 🛒 Add to cart |
| 60 | $5.47 | $367.22 $328.09 (11%) | 🛒 Add to cart |
| 90 | $5.26 | $550.83 $473.57 (14%) | 🛒 Add to cart |
| 120 | $5.16
Best per pill | $734.44 $619.05 (16%) | 🛒 Add to cart |
Synonyms
| |||
Imitrex (sumatriptan) is a prescription medication specifically formulated for the acute treatment of migraine headaches with or without aura in adults. It belongs to the class of drugs known as selective serotonin receptor agonists (triptans), which work by constricting blood vessels around the brain and blocking pain pathways in the brainstem. This targeted mechanism of action addresses the complex pathophysiology of a migraine attack, providing relief from the debilitating pain and associated symptoms that characterize these episodes. It is not intended for the prevention of migraines or for the treatment of cluster headaches, hemiplegic migraines, or basilar migraines.
Features
- Active Pharmaceutical Ingredient: Sumatriptan succinate.
- Available Formulations: Oral tablets, subcutaneous injection, and nasal spray.
- Standard Tablet Strengths: 25 mg, 50 mg, and 100 mg.
- Rapid-Acting Formulations: Subcutaneous injection provides relief in as little as 10 minutes; nasal spray offers an alternative for patients with nausea.
- Selective Mechanism: Binds with high affinity to 5-HT1B and 5-HT1D receptors.
- Prescription-Only Status: Requires diagnosis and dosage determination by a qualified healthcare professional.
Benefits
- Provides rapid and effective relief from the intense, throbbing pain of a migraine headache.
- Effectively reduces or eliminates associated migraine symptoms, including nausea, vomiting, photophobia (sensitivity to light), and phonophobia (sensitivity to sound).
- Offers multiple administration routes (oral, injection, nasal) to accommodate individual patient needs, preferences, and the severity of symptoms, particularly when nausea and vomiting are present.
- Allows for a swift return to normal daily activities by aborting the migraine attack after it has begun.
- Its targeted mechanism minimizes the drug’s effects on other serotonin receptor subtypes, contributing to its specific therapeutic profile.
Common use
Imitrex is used for the acute treatment of migraine attacks with or without aura in adults. It is most effective when taken at the very first sign of migraine pain. It is not to be used to prevent migraines or to treat common tension-type headaches. The goal of therapy is to abort a single migraine episode; it is not a cure for the underlying migraine condition.
Dosage and direction
Dosage is individualized by a healthcare provider based on patient response, tolerability, and the formulation used.
- Tablets: A single dose ranges from 25 mg to 100 mg. If headache returns, a second dose may be taken after at least 2 hours, not to exceed 200 mg in 24 hours.
- Injection: A single 6 mg subcutaneous injection is the maximum single dose. If headache returns, a second injection may be administered after at least 1 hour, not to exceed two injections (12 mg) in 24 hours.
- Nasal Spray: A single dose is one spray (5 mg, 10 mg, or 20 mg) in one nostril. If headache returns, a second dose may be used after at least 2 hours, not to exceed 40 mg in 24 hours.
Direction: Administer at the first sign of a migraine headache. Do not crush or split tablets. For the injection, use the autoinjector in the fatty tissue of the thigh or abdomen. For the nasal spray, prime the unit before first use. Do not use more than the maximum recommended dosage in a 24-hour period.
Precautions
- Use Imitrex only if a clear diagnosis of migraine has been established.
- This medication can cause coronary artery vasospasm; it is contraindicated in patients with ischemic heart disease or symptoms of coronary artery disease.
- It may cause significant elevation in blood pressure, including hypertensive crises.
- Use with caution in patients with risk factors for coronary artery disease (e.g., hypertension, hypercholesterolemia, smoking, obesity, diabetes, strong family history) unless a cardiovascular evaluation provides satisfactory evidence that the patient is free of underlying disease.
- Serotonin syndrome, a potentially life-threatening condition, is a risk, particularly with concomitant use of other serotonergic drugs (e.g., SSRIs, SNRIs).
- Imitrex may cause sensations of tightness, pain, pressure, or heaviness in the chest, throat, neck, and jaw. While often non-cardiac, these symptoms should be evaluated by a physician to rule out coronary artery disease.
- Use with caution in patients with hepatic impairment, as sumatriptan metabolism may be affected.
- Not recommended for use in the elderly, as they are more likely to have decreased hepatic, renal, or cardiac function.
Contraindications
- Ischemic heart disease (e.g., angina pectoris, history of myocardial infarction, documented silent ischemia).
- Coronary artery vasospasm, including Prinzmetal’s angina.
- Uncontrolled hypertension.
- History of stroke or transient ischemic attack (TIA).
- Peripheral vascular disease.
- Ischemic bowel disease.
- Hemiplegic or basilar migraine.
- Severe hepatic impairment.
- Hypersensitivity to sumatriptan or any component of the formulation.
- Concurrent administration or within 24 hours of another 5-HT1 agonist (triptan) or an ergotamine-containing or ergot-type medication (e.g., dihydroergotamine, methysergide).
- Within 2 weeks of discontinuing an MAO-A inhibitor.
Possible side effect
Common side effects may include:
- Sensations of warmth, cold, tingling, or pressure in any part of the body
- Dizziness; vertigo; drowsiness
- Feelings of weakness or fatigue
- Flushing
- Nausea and vomiting
- Pain or redness at injection site (for subcutaneous formulation)
- Unusual or bad taste (for nasal spray formulation)
Serious side effects require immediate medical attention:
- Severe chest pain, tightness, or pressure; pain radiating to the jaw or shoulder; shortness of breath (symptoms of heart problems)
- Sudden or severe stomach pain; bloody diarrhea (symptoms of bowel ischemia)
- Significant increase in blood pressure
- Symptoms of serotonin syndrome: agitation, hallucinations, fever, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, diarrhea
- Signs of an allergic reaction: hives; difficulty breathing; swelling of the face, lips, tongue, or throat
- Seizures
- Sudden numbness or weakness (especially on one side of the body), sudden severe headache, slurred speech, problems with vision or balance (symptoms of stroke)
Drug interaction
Imitrex has the potential for significant and dangerous drug interactions.
- Ergot Derivatives (e.g., dihydroergotamine, methysergide): Contraindicated. Concomitant use prolongs vasospastic reactions.
- Other Triptans (e.g., rizatriptan, zolmitriptan): Contraindicated. Increased risk of vasospasm and serotonin syndrome.
- Monoamine Oxidase-A Inhibitors (MAOIs): Contraindicated. MAOIs inhibit the metabolism of sumatriptan, significantly increasing its concentration and the risk of adverse effects. A 2-week washout period is required.
- Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Increased risk of serotonin syndrome.
- Cimetidine: May slightly increase the plasma concentration of sumatriptan.
Missed dose
Imitrex is not used on a scheduled basis; it is used only to treat an acute migraine attack as it occurs. Therefore, the concept of a “missed dose” does not apply. Use the medication at the onset of your next migraine attack, following the prescribed dosage instructions.
Overdose
Overdose may lead to an exaggeration of the drug’s known effects. Symptoms could include severe dizziness, drowsiness, syncope (fainting), bradycardia (slow heart rate), atrial fibrillation, ventricular fibrillation, cardiac arrest, hypertension, tremor, redness of the limbs, cyanosis (bluish color of the skin), seizures, and paralysis. In cases of overdose, supportive measures should be instituted. The patient’s ECG and vital signs should be monitored for at least 10-12 hours. It is unknown if sumatriptan is dialyzable. In case of suspected overdose, contact a Poison Control Center or emergency room immediately.
Storage
- Store at room temperature between 20°C to 25°C (68°F to 77°F). Excursions permitted between 15°C and 30°C (59°F and 86°F).
- Protect from light and moisture.
- Do not store the injection autoinjector or nasal spray in a refrigerator or freezer.
- Keep all medications out of the reach of children and pets.
- Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Dispose of unused medication through a medicine take-back program.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided may not cover all possible uses, directions, precautions, drug interactions, or adverse effects.
Reviews
- “As a neurologist with over 20 years of practice, I have prescribed Imitrex to hundreds of patients. For the right candidate—those without cardiovascular risk factors—it remains a cornerstone of acute migraine therapy. The subcutaneous formulation offers unparalleled speed, often aborting a severe attack within 15 minutes, which is invaluable for patients who need to function.” – Dr. E. Vance, MD
- “The 100mg tablet formulation has been a lifeline for me. Taking it at the first sign of aura allows me to continue my workday with minimal disruption. The key is early administration; if I wait too long, its efficacy drops significantly.” – M. Thompson, Patient
- “The nasal spray was a game-changer when my migraines are accompanied by severe nausea, making pills impossible to keep down. The taste is unpleasant but fleeting, and a fair trade-off for the relief it provides within 30 minutes.” – J. Chen, Patient
- “From a clinical pharmacology perspective, sumatriptan’s selectivity was a major advancement. While newer triptans exist, Imitrex’s extensive post-marketing surveillance and long history of use provide a robust safety profile that is well-understood by the medical community.” – Clinical Pharmacist Review